Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice changes in their hands after starting Mounjaro: coldness, tingling, or an occasional numbness that wasn't there before. These sensations are real, they have explanations rooted in how tirzepatide works, and most of them resolve on their own. This page walks through the most common hand-related experiences reported during Mounjaro treatment, what the evidence says, and the signs that do warrant a call to your prescriber. As a prescription-only medicine, Mounjaro is assessed and prescribed by a qualified clinician; any new or persistent symptom should be reviewed in that clinical relationship, not self-diagnosed online.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people notice is that their hands feel colder than usual, sometimes from the first few weeks of treatment. A widely held assumption is that the medicine itself is causing poor circulation. That's understandable, but it's not quite the whole picture.
When caloric intake drops significantly (which is exactly what Mounjaro's appetite-reducing mechanism achieves) the body redirects blood flow towards core organs and away from the extremities. This is a normal physiological response to consuming less energy, not a sign that anything is going wrong with your cardiovascular system. The hands and feet are simply the furthest points from the heart, so they feel the shift first.
The specific question of cold hands on Mounjaro deserves its own attention because the experience is common enough to cause unnecessary alarm. Staying well hydrated, keeping moving, and wearing warmer layers can help while your body adjusts to a lower caloric baseline. For the vast majority of people, the sensation settles as treatment continues and eating patterns stabilise. If it doesn't, or if the coldness is extreme, that's worth raising at your next clinical review.
Tirzepatide itself is a dual GIP and GLP-1 receptor agonist, it works on appetite and blood-sugar regulation, not directly on peripheral circulation. The NHS tirzepatide page lists the known side effects, and cold extremities do not appear among the pharmacologically confirmed ones; what does appear is a gastrointestinal-led profile (nausea, diarrhoea, constipation) which is worth knowing about separately.
A smaller group of people report tingling, pins-and-needles, or mild numbness in the hands or feet during treatment. This is less universal than cold hands and slightly harder to attribute to a single cause.
One possibility is nutritional. Rapid weight loss (especially with reduced food variety) can affect B-vitamin intake, and B12 and B6 deficiencies are associated with peripheral tingling. Protein intake also matters: when appetite is suppressed substantially, some people find they eat less protein than their body needs, which can have downstream effects on nerve function over time.
A second possibility is positional or mechanical: people sometimes change their activity patterns during treatment, sitting differently, exercising more, or carrying less. None of these are harmful, but they can temporarily compress nerves in the wrist or forearm.
The question of tingling in the hands and feet specifically is worth reading if this is your primary concern. The key threshold is persistence and pattern: occasional tingling that comes and goes is different from a constant numbness in a defined nerve distribution, which would need a proper clinical assessment rather than a website explanation.
Ensure your prescriber knows if you have a history of conditions that affect circulation or nerve function, this is exactly the kind of medical history that informs the initial consultation.
Most hand sensations during Mounjaro treatment fall into the category of uncomfortable but explicable. There are, though, specific presentations that should prompt you to seek medical help rather than wait.
Sudden weakness in one hand or arm (particularly if it comes with facial drooping, slurred speech, or vision changes) is a stroke warning and requires a 999 call, not a prescriber message. This is not a known side effect of tirzepatide; it would be a separate medical emergency that happens to coincide with treatment.
Severe, progressive numbness in both hands that is worsening week by week is also worth a proper evaluation, as is any hand symptom accompanied by persistent severe stomach pain radiating to the back. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines highlighting that acute pancreatitis (while infrequent) is a known serious risk; abdominal pain is the central symptom, and if your hand discomfort is somehow part of a broader picture of severe GI pain, tell a clinician the same day. You can report any suspected side effect through the MHRA Yellow Card scheme, which is open to patients as well as healthcare professionals.
For concerns that don't meet that urgent threshold, your prescriber is still the right first call. Mounjaro is a prescription-only treatment with ongoing clinical oversight built into how it's dispensed, that relationship exists precisely for questions like these.
The practical upshot of all this is straightforward. Keep a short note of when hand sensations appear, after a dose increase, at a particular time of day, after activity, or seemingly at random. That pattern is useful information for a prescriber. Mention it at your next review, or contact your aftercare team sooner if the symptom is getting worse or worrying you.
If you're thinking about starting treatment and wondering how hand symptoms would be managed, that's a sensible question to raise during your consultation. You can also read about whether Mounjaro causes cold hands and feet for a more detailed look at the circulation question specifically.
For context on the broader costs and considerations involved in private treatment, the Mounjaro price comparison page sets out what's typically included in a private prescription service, useful if you're weighing up your options. And if you'd like to understand more about tirzepatide's place among available treatments, the tirzepatide overview covers the clinical picture in full.
Hand sensations during Mounjaro treatment are, for most people, a passing inconvenience. They're worth knowing about. They're rarely a reason to stop treatment without speaking to a clinician first, and always a reason to ask.
If you'd like to speak to our prescribers about any symptoms you're experiencing, or to start a clinical assessment, begin your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.